spironolactone has been researched along with Aortic Aneurysm in 3 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Aortic Aneurysm: An abnormal balloon- or sac-like dilatation in the wall of AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No reports have described mycotic pseudoaneurysm in the aortic arch in a diabetic patient associated with primary aldosteronism." | 5.36 | Successful treatment of a mycotic aortic pseudoaneurysm in a patient with type 2 diabetes mellitus while treating primary aldosteronism with spironolactone. ( Fukata, M; Furukawa, H; Ito, H; Ito, Y; Konishi, T; Matsuzawa, Y; Nishikawa, T; Okura, K; Saito, J; Yoshimura, K, 2010) |
| "No reports have described mycotic pseudoaneurysm in the aortic arch in a diabetic patient associated with primary aldosteronism." | 1.36 | Successful treatment of a mycotic aortic pseudoaneurysm in a patient with type 2 diabetes mellitus while treating primary aldosteronism with spironolactone. ( Fukata, M; Furukawa, H; Ito, H; Ito, Y; Konishi, T; Matsuzawa, Y; Nishikawa, T; Okura, K; Saito, J; Yoshimura, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurobe, H | 1 |
| Hirata, Y | 1 |
| Matsuoka, Y | 1 |
| Sugasawa, N | 1 |
| Higashida, M | 1 |
| Nakayama, T | 1 |
| Maxfield, MW | 1 |
| Yoshida, Y | 1 |
| Shimabukuro, M | 1 |
| Kitagawa, T | 1 |
| Sata, M | 1 |
| Ito, Y | 1 |
| Yoshimura, K | 1 |
| Matsuzawa, Y | 1 |
| Saito, J | 1 |
| Ito, H | 1 |
| Furukawa, H | 1 |
| Okura, K | 1 |
| Fukata, M | 1 |
| Konishi, T | 1 |
| Nishikawa, T | 1 |
| Noji, Y | 1 |
| Hifumi, S | 1 |
| Nagayoshi, T | 1 |
| Nagasawa, S | 1 |
| Kasuga, T | 1 |
| Miwa, K | 1 |
| Kobayashi, T | 1 |
| Mabuchi, H | 1 |
3 other studies available for spironolactone and Aortic Aneurysm
| Article | Year |
|---|---|
Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model.
Topics: Animals; Aortic Aneurysm; Blood Pressure; Chemokine CCL2; Disease Models, Animal; Disease Progressio | 2013 |
Successful treatment of a mycotic aortic pseudoaneurysm in a patient with type 2 diabetes mellitus while treating primary aldosteronism with spironolactone.
Topics: Aged; Aneurysm, False; Aneurysm, Infected; Aortic Aneurysm; Blood Vessel Prosthesis Implantation; Di | 2010 |
Sixteen-slice computed tomography, transthoracic real-time 3-dimensional echocardiography and magnetic resonance imaging assessment of a long-term survivor of rupture of sinus of valsalva aneurysm.
Topics: Aged; Aortic Aneurysm; Aortic Rupture; Diagnosis, Differential; Diuretics; Drug Therapy, Combination | 2005 |